Long-Term Treatment With Human Immunoglobulin for Antisynthetase Syndrome-Associated Interstitial Lung Disease

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Long-Term Treatment With Human Immunoglobulin for Antisynthetase Syndrome-Associated Interstitial Lung Disease

By National Jewish Health FEATURING Liudmila Kastsianok, Jinny Tavee

83 views

April 22, 2022

Dr. Liudamila Kastsianok, M.D., RhMSUS, FACR Associate Professor of Rheumatology at National Jewish Health with ...
read more ↘ contributing faculty, Jinny Tavee, MD Associate Professor, Chief for the Division of Neurology Department of Medicine at National Jewish Health discuss “Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respir Med. 2019 Jul-Aug;154:6-11. doi: 10.1016/j.rmed.2019.05.012. Epub 2019 May 21. PMID: 31176796” . The journal article summary link is https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/ild-article-summary-april-final.aspx
↖ read less

Comments 0